The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...